Impax, AstraZeneca Get Win In Generic Zomig Patent Case
A Delaware federal judge has given a victory to Impax Laboratories Inc. and AstraZeneca AB in their patent infringement suit over Lannett Holdings Inc.'s planned generic version of the migraine medication...To view the full article, register now.
Already a subscriber? Click here to view full article